Haroon Faraz MD FACC,FSCAI
Interventional Cardiology, Peripheral Endovascular Interventional Cardiology
Interventional Cardiology
Join to View Full Profile
400 Frank W Burr BlvdTeaneck, NJ 07666
Phone+1 201-928-2300
Fax+1 201-692-3262
Dr. Faraz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Haroon Faraz, MD is a Cardiology specialist located in Teaneck, NJ, with subspecialties in Interventional Cardiology and Peripheral Endovascular Interventional Cardiology. His education includes fellowships and residencies at Detroit Medical Center/Wayne State University and Wayne State University School of Medicine. His professional experience involves cases concerning cardiogenic shock, interventional cardiology, cardiac catheterization, heart failure, and cardiac critical care. He has significant publications on cardiovascular research and has been involved in multiple clinical trials. Dr. Faraz holds the Healthgrade Honor Roll award and is a fellow of the American College of Cardiology.
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Interventional Cardiology, 2011 - 2012- Detroit Medical Center/Wayne State UniversityFellowship, Cardiovascular Disease, 2008 - 2011
Wayne State University School of MedicineResidency, Internal Medicine, 2004 - 2007
Brown UniversityInternship, Transitional Year, 2003 - 2004
Dow University of Health SciencesClass of 2001
Certifications & Licensure
NJ State Medical License 2012 - 2027
MI State Medical License 2004 - 2013
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Healthgrade Honor Roll healthgrades
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Cardiogenic Shock Working Group Registry Start of enrollment: 2017 Dec 04
- Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function Start of enrollment: 2021 Apr 13
- Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial Start of enrollment: 2019 Dec 12
Publications & Presentations
PubMed
- Outcomes among patients with coronary bifurcation lesions undergoing Impella-supported high-risk percutaneous coronary intervention.Aneel S Maini, Arsalan Abu-Much, Björn Redfors, Jason R Wollmuth, Mir B Basir
American Heart Journal. 2025-12-01 - 1 citationsMechanical circulatory support in high-risk elective PCI: rationale and design of the PROTECT IV trial.Norman Mangner, Samin K Sharma, Chris O'Connor, Amir Kaki, George D Dangas
Eurointervention. 2025-09-30 - The Impact of the Multidisciplinary Team on the Volume of Complex Cardiovascular Interventions.David Landers, Mark Anderson, Ryan Kaple, Pranaychandra Vaidya, Haroon Faraz
JACC. Advances. 2025-08-01
Press Mentions
Hackensack Meridian Health Now Providing Minimally Invasive Technology to Help Control High Blood PressureAugust 8th, 2024- Valley Hospital, HUMC, Morristown Among 1st Sites of Important Impella ECP Pivotal TrialMay 4th, 2023
- The Valley Hospital Among First to Participate in Impella ECP Pivotal TrialMay 1st, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
